A widely available drug helps prevent upper gastrointestinal bleeding in critically ill adults on a breathing machine, according to the results of a global study and meta-analysis led by researchers ...
A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) found the risk of developing Parkinson's disease was 76% higher among those with a history of damage to the lining of their ...
A study published in The Lancet examined celecoxib use versus naproxen in patients with cardiothrombotic diseases and arthritis. Francis K. L. Chan, MD, of the Chinese University of Hong Kong, and ...
Upper gastrointestinal involvement in CD appears uncommon and generally does not require different immunosuppressive treatment strategies. Response and remission rates to immunosuppressive therapy was ...
FOSTER CITY, Calif. & HAYWARD, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced longer-term efficacy and safety results from Arm ...
BERLIN — Women who use menopausal hormone therapy (MHT; ie, hormone replacement therapy) have an up to 30% reduction in the risk of developing esophageal and gastric cancers compared to nonusers, ...
Researchers at Karolinska Institutet in Sweden have identified eight primary factors that increase the risk of a common bleeding complication after heart attack. Some of these factors are already ...
On Saturday, Gilead Sciences Inc (NASDAQ:GILD) and Arcus Biosciences Inc (NYSE:RCUS) released longer-term efficacy and safety results from Arm A1 of the Phase 2 EDGE-Gastric study. The updated data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results